Fig. 1From: The ratio of ADSCs to HSC-progenitors in adipose tissue derived SVF may provide the key to predict the outcome of stem-cell therapyCorrelation between clinical outcome and gender (a), age (b), clinical conditions (c), different routes of injections (d). a The mean benefit index is shown as the height of the bars for males and females, with the error bars representing the 95% confidence interval. b A scatter plot of the age versus benefit index is shown. c The breakdown of distribution of the benefit index in various clinical conditions, where Category #1 represents orthopedic applications and Category #2 represents organ or tissue dysfunctions. d The number of SVF-treated patients with various routes of injection is shown as the height of the bars, with the benefit index shown on the X-axisBack to article page